Linjing Mu

Research focus: development of novel PET tracers

[Linjing Mu @LinjingM]

@elonmusknews30 8

[Linjing Mu @LinjingM]

@ElonMuskZAB 8

[Linjing Mu @LinjingM]

@ohhanxiety 48

[ChemEurJ: Chemistry - A European Journal @ChemEurJ]

Discovery of 1,3,4-Oxadiazin-5-One Derivative CJ1-34 as a Partial ATP Synthase Inhibitor for CNS Applications (@schibli_CRS, Linjing Mu @LinjingM and co-workers) • https://t.co/wwTxm6Iuq2

[D-CHAB @ETH_DCHAB]

The D-CHAB @ETH_en invites #applications for two open #fullprofessor positions at the Laboratory of Organic Chemistry :
1. Synthetic Organic Chemistry
2. (Bio)Analytical Chemistry
Please apply online by Nov 15, 2024! Details:

https://t.co/mUot8hhsOD

[ChemBioChem @ChemBioChem]

Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[11C]YH132: Application in Drug Development and Neurodegenerative Diseases (Linjing Mu and co-workers) #openaccess https://t.co/mR9s8NL495

[Roger Schibli @schibli_CRS]

Thirty amazing and happy radiopharmacists from all over the world successfully finished the ETH Zurich #ETH_en module of the Certificate of Advanced Studies in Radiopharmaceutical Chemistry/Radiopharmacy https://t.co/tagqhAEKxo! Thank you to everyone who contributed!

[JNM @JournalofNucMed]

New PET tracer visualizes and quantifies MAGL in preclinical studies and has the potential to enable precision pharmacology during drug development for neurological disorders. https://t.co/UQyv2hACTN

#PETimaging #NuclearMedicine @he_yingfan27720 @LinjingM

[Roger Schibli @schibli_CRS]

Terbium-161 developed at the Paul Scherrer Institute @psich_en hits the clinic | Labs & User Services | Paul Scherrer Institut (PSI) https://t.co/wCkVCX792Q

[Linjing Mu @LinjingM]

@michellefrei13 @ETH_DCHAB @ETH_en Hi Michelle, So great! Congratulations!!! We met already in the flight in May, right? I am looking forward to having a coffee with you at ETH. Linjing

[D-CHAB @ETH_DCHAB]

Are you curious to know how it is to do #research @ETH_DCHAB #Hönggerberg campus of @ETH_en? Get a glimpse of a typical day by joining us for a 210-second journey! #imagefilm #Chemistry
Learn more on https://t.co/bl1gTUwrsi

Watch the full movie here: https://t.co/KJokfdlw7l

[Roger Schibli @schibli_CRS]

Proud to be honored as a Fellow of the Society of Radiopharmaceutical Sciences @SocRadiophSci during the opening of #iSRS2023.

[Linjing Mu @LinjingM]

@crf_stanford @StanfordRad @StanfordMIPS So sad. deepest condolence to his family.

[Roger Schibli @schibli_CRS]

The Institute of Pharmaceutical Sciences at @ETH_DCHAB is seeking an Assistant Professor (tenure track) of Medicinal Chemistry. Details and links to the application can be found here: https://t.co/CCX6ASVs42

[Linjing Mu @LinjingM]

We are hiring… https://t.co/yFiaGi3FjN

[Linjing Mu @LinjingM]

@vanDamLab Congratulations!

[Kristina Herfert @Herfert_lab]

📣Please retweet: We have an open Ph.D. position to join our team working on simultaneous PET/fMRI in rats. If you are interested, see: https://t.co/URvCS1GW0l

[Roger Schibli @schibli_CRS]

Promising results from a new PET tracer targeting the mitochondrial ATP synthase ATP5A reported at the #EANM22 by Caitlin Jie.

[European Society for Molecular Imaging - ESMI @ESMI_society]

📢 The abstract submission system for #EMIM2023 has just been opened!
Deadline for submission is 22 Nov. '22 (sharp).
Submit, check out on rules & categories at https://t.co/yWOEFJ5Xdz, mark your calendar 📅 and just enjoy planning for a wonderful EMIM in spring in Salzburg.

[Roger Schibli @schibli_CRS]

Systematic study of cleavable linkers to reduce renal retention of radiopeptides and their metabolites by Valpreda et al. now available online in Bioorganic & Medicinal Chemistry https://t.co/KK1QjVpYB4